new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




  

Mochida Pharmaceutical Co Ltd patents

Recent patent applications related to Mochida Pharmaceutical Co Ltd. Mochida Pharmaceutical Co Ltd is listed as an Agent/Assignee. Note: Mochida Pharmaceutical Co Ltd may have other listings under different names/spellings. We're not affiliated with Mochida Pharmaceutical Co Ltd, we're just tracking patents.

ARCHIVE: New 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "M" | Mochida Pharmaceutical Co Ltd-related inventors




Date Mochida Pharmaceutical Co Ltd patents (updated weekly) - BOOKMARK this page
03/23/17Composition for reducing new-onset diabetes
02/02/17Factor ixa inhibitors
01/12/17Compositions and methods for treating non-alcoholic steatohepatitis
12/29/16Method for evaluation of function of phagocyte
12/01/16Novel pyrazole derivative
07/28/16Compositions and methods for treating non-alcoholic steatohepatitis
06/16/16Diagnosis of respiratory tract infectious disease using urine specimens
06/09/16Self-emulsifying composition of omega3 fatty acid
06/09/16Diagnosis of respiratory tract infectious disease using blood specimens
06/02/16Self-emulsifying composition of omega3 fatty acid
04/28/16Biomarker of nrf2 activation
03/31/16Composition for preventing the occurrence of cardiovascular event in multiple risk patient
03/10/16Composition for regeneration of cartilage
02/18/16Composition and/or preventing onset and/or recurrence of cardiovascular events
02/04/16Compositions and methods for treating non-alcoholic steatohepatitis
12/24/15Factor ixa inhibitors
11/19/15Factor ixa inhibitors
11/12/15Factor ixa inhibitors
10/08/15Self-emulsifying composition of w3 fatty acid
09/24/15Cyclic amide derivative
09/24/15Cyclic amide derivative
09/17/15Compositions and methods for treating non-alcoholic steatohepatitis
09/17/15Compositions and methods for treating non-alcoholic steatohepatitis
09/10/15Composition for reducing new-onset diabetes
09/03/15Marker associated with non-alcoholic steatohepatitis
08/27/15Novel anti-presepsin antibody
08/13/15Cyclic amide derivative
06/18/15Novel pyrazole derivative
05/21/15Cardiovascular disease primary prevention agent for patients having high blood levels of high-sensitivity c-reactive protein
05/14/15Novel pyrazole derivative
05/14/15Novel pyrazole derivative
03/19/15Easily administrable solid preparation
02/19/15Compositions and methods for treating non-alcoholic steatohepatitis
12/25/14Novel pyrazole derivative
12/25/14Novel pyrazole derivative
12/18/14Composition for preventing the occurrence of cardiovascular event in multiple risk patient
10/16/14Easily dosable solid preparation
07/31/14Composition for regeneration of cartilage
07/31/14Diagnosis of respiratory tract infectious disease using blood specimens
06/05/14Anti-obesity agent comprising high-purity epa
02/27/14Self-emulsifying composition of omega3 fatty acid
02/27/14Cyclic amide derivative
02/20/14Anti-cd14 antibody fusion protein
02/06/14Therapeutic agent for diastolic congestive heart failure
11/14/13Agent for inhibiting elevation in blood glucose level
10/24/13Method for selecting patient to be given drug for treating septicemia
08/22/13Method for diagnosing alzheimer's disease using-soluble gpvi
08/22/13Novel 3-hydroxyisothiazole 1-oxide derivatives
08/15/13Novel 3-hydroxyisothiazole 1-oxide derivatives
08/08/13Cyclic amide derivative
07/25/13Composition for treatment of cartilage disease
05/09/13Omega3 fatty acid compound preparation
04/18/13Anti-platelet membrane glycoprotein vi monoclonal antibody
03/14/13Composition and/or preventing onset and/or recurrence of cardiovascular events
01/31/13Novel aryl urea derivative
01/10/13Novel platelet activation marker and determination thereof
12/06/12Method of analyzing human scd14-st
11/01/12Novel 3-hydroxyisothiazole 1-oxide derivative
10/18/12Compositions and methods for treating non-alcoholic steatohepatitis
04/05/12Easily administrable solid preparation
02/23/12Method for diagnosing endometriosis and diagnostic kit for endometriosis
09/08/11Anti-platelet membrane glycoprotein vi monoclonal antibody
05/19/11Composition for preventing cardiovascular event in high-risk patient
05/12/11Novel heterocyclidene acetamide derivative
04/14/11Method for evaluation of function of phagocyte
Patent Packs
01/21/10Composition for treatment of cartilage disease
01/21/10Heterocyclidene-n-(aryl) acetamide derivative
04/23/09Composition and/or preventing recurrence of stroke
04/09/09Anti-platelet membrane glycoprotein vi monoclonal antibody







ARCHIVE: New 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Mochida Pharmaceutical Co Ltd in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Mochida Pharmaceutical Co Ltd with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';